Hygie31 has reached a historic milestone and established itself as the European leader in local health. In 2025, the group achieved a consolidated turnover of 5 billion euros (+52% vs 2024)now uniting a powerful European network of 2,583 points of saleA unique, virtuous and value-generating health "ecHosystem” whose ambition is clear: to become the European leader in local health by carrying out a public-service mission; "Health for everyone and everywhere". The group is transforming the pharmacy model to ensure accessible health for everyone, everywhere, moving from a curative approach to preventive medicine.

Accessibility: a long-held vision and conviction

Faced with the major challenge of "healthy longevity", Hygie31 is supporting the transformation of the traditional pharmacy. Based on the "4P" medicine (Preventive, Participatory, Personalised and Predictive), the group is deploying a unique local healthcare service. With a territorial network representing nearly 10% of the French market and a growing presence in Spain and Italy, Hygie31 facilitates access to care for millions of patients and customers in Europe.

A response to a health system under pressure

This vision of accessibility responds to a simple observation: our current healthcare system is at its limits and must face several critical challenges:

Although the French model is considered to be one of the best in the world, the "everything for free" system is reaching its limits, exacerbated by a curative focus that widens the deficit. Conversely, countries such as Italy and Spain, with tax-based funding for the system, allow better budgetary control and have already transitioned to paid preventive medicine (e.g. melanoma screening in Italy for €30).

To support its vision for the future of healthcare, the group is supporting the transition of pharmacies towards a preventive model, through 3 stages:

Reinforce its model to influence markets through a structured European approach

In 2025, Hygie31 accelerated its European development and positioned itself as a shield for pharmacists’ independence The group has taken a new step in its development by adopting a network strategy in Spain, with ambitions identical to those of France. It has also consolidated its positions through five strategic growth areas, diversifying its expertise between digital and territorial networking:

Hygie31’s strength is based on a diversified business model centred around 5 key areas:

2025: A record year of growth and integration

One of the "ecHosystem"’s strengths lies in the successful integration of its various external growths. Thus, Pharmacorp, 1st group to have joined Hygie31 in 2022 with 350 members — now boasts 650 affiliated pharmacies and a 12% increase in turnover; Quartz, which joined Hygie31 in 2024, recorded a growth of 40% in its number of members and 34% in its turnover. Thanks to its unique value proposition, the group is strengthening member loyalty and accelerating the recruitment of new pharmacists, who are attracted by its comprehensive service offering.

2025 was also marked by the group's European expansion

In Spain as in Italy, the goal is the same: to create the leader in pharmacy in each country, backed by the Pharmacie Lafayette brand.

E-commerce: Hygie31 is building a European omnichannel player

With six e-commerce sites, serving both B2B and B2C customers in the Wellness, Health, and Medical Equipment sectors, Hygie31 reports an 11% increase in revenue for its subsidiary, Dhygietal, which includes cocooncenter.com, parapharmacielafayette.com, lasante.net and distrimed.comDespite a challenging e-commerce sector in France, Dhygietal’s turnover has increased from €90 million to €100 million: that’s one product sold every two seconds!

Key figures:

The group has replaced the heterogeneity of its former tools (ERP systems, technologies, and business solutions) with a unified digital ecosystem, ensuring greater agility and immediate efficiency gains across all its websites.

In 2026, Hygie31 continues its growth: performance is at the core of our DNA

In 2026, the group continues its development strategy with strong organic growth and further external growth expected. It thus aims toreach a turnover of €6 billion (+20%), 3,200 points of sale (+24%) and 2,793 pharmacies (+13%), including 1,960 in France and 833 internationally.